The California-based firm reported revenues of $2.5bn for 2020, and employs more than 8,000 people across 35 countries. Its work in the latter sector ranges from autoimmune and diabetes testing, and newborn screening, to diagnosing bacterial or viral infections.īio-Rad’s Reliance SARS-CoV-2 RT-PCR Test – a molecular diagnostic for individuals suspected by their healthcare provider of having Covid-19 – gained an FDA EUA on 15 January 2021. The company reported total revenues of €3.12bn ($3.6bn) for 2020, and currently employs about 12,800 people globally.īio-Rad is an American developer and manufacturer of products for the life sciences research and clinical diagnostics markets. In the summer of 2020, bioMérieux gained a CE marking and an EUA for its VIDAS SARS-CoV-2 test – which is an immunoassay used to detect IgM and IgG antibodies, and diagnose individuals previously infected with the virus. The bioMérieux VIDAS immunoassay gained approval for use in SARS-CoV-2 testing last year (Credit: bioMérieux) Its main focus is the detection of infectious diseases including HIV, sepsis, gastrointestinal infections, and respiratory diseases like pneumonia and the novel coronavirus. Through its portable, hand-held blood analysers, Abbott is also looking to meet the growing need for point-of-care testing kits capable of producing fast, accurate and reliable results.Īnd, throughout the global pandemic, the company has gained regulatory approvals for multiple SARS-CoV-2 tests, with its BinaxNOW COVID-19 Ag Card Home Test becoming the first at-home, virtually guided coronavirus diagnostic to gain an FDA EUA (emergency use authorisation) on 16 December 2020.Ībbott currently has more than 109,000 employees across the world and reported a total revenue of $34.6bn for 2020.įrench biotech company bioMérieux specialises in diagnostic solutions – and provides IVD devices, reagents, software and services used by laboratories across more than 160 countries globally. Within molecular diagnostics, its current portfolio includes a range of lab-based tests used to detect genetic disorders, infectious diseases and cancers. Illinois-based firm Abbott is currently one of the biggest medical device manufacturers in the world, and operates across a wide range of sub sectors including cardiovascular and diabetes care, pharmaceuticals, neuromodulation and diagnostics. The world’s biggest diagnostics companies in 2021 1. With the biggest companies in the diagnostics sector likely to both contribute to and benefit from this expected growth, we take a look at who the major players in the industry are right now. It should therefore come as no surprise that many analysts are anticipating the market for in vitro diagnostic (IVD) products will significantly increase in value, at a CAGR (compound annual growth rate) of roughly 4.5%, over the next few years. The likes of Roche, Abbott and Thermo Fisher Scientific were among numerous global firms that raced to develop fast, accurate methods for detecting patients infected with the SARS-CoV-2 virus and, just as importantly, how quickly it was spreading among populations. The unprecedented demand for Covid-19 testing kits seen last year resulted in many of the world’s biggest diagnostics companies being thrust into the limelight. The biggest in vitro diagnostics companies in the world right now are spread across the US, Europe and the Asia-Pacific regionĪs an industry, in vitro diagnostics has gained more interest than ever before during the past year (Credit: Chinnapong/Shutterstock)
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |